The C1q Antibodies test, serum measures the levels of autoantibodies directed against the C1q protein, a crucial component of the classical complement pathway. Detecting these antibodies is particularly valuable in the evaluation, diagnosis, and monitoring of systemic lupus erythematosus (SLE), as well as associated complications like lupus nephritis. Elevated titers of anti-C1q antibodies strongly correlate with active renal disease and severe inflammation. Clinicians utilize this specialized immunological assay alongside other complement markers to assess disease activity, predict flare-ups, and guide targeted therapeutic management for autoimmune disorders affecting multiple vital organ systems.